Cat. No. | Product name | CAS No. |
DC9613 |
CCG-63808
CCG-63808 is a reversible inhibitor of regulator of G-protein signaling (RGS) proteins. |
620113-73-7 |
DC22050 |
CCI-006
CCI-006 (CCI 006) is a novel inhibitor of MLL-rearranged and CALM-AF10 translocated leukemias that share common leukemogenic pathways. |
292053-42-0 |
DC22049 |
CCI-007
CCI-007 (CCI 007) is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485. |
939228-52-1 |
DC26030 |
CCMI
Featured
CCMI is a positive allosteric modulator of α7 neuronal nicotinic acetylcholine receptors (nAChR). |
917837-54-8 |
DC12639 |
CCR1 inhibitor 19e
CCR1 inhibitor 19e is a novel potent, selective CCR1 antagonist with IC50 of 6.8 nM, inhibits CCR1chemotaxis in THP-1 cells with IC50 of 28 nM.. |
1220026-26-5 |
DC23528 |
CCR10 antagonist 1
CCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM. |
1191031-97-6 |
DC12177 |
CCR2 antagonist 1
CCR2 antagonist 1 is a high-affinity and long-residence-time CCR2 antagonist, with a Ki of 2.4 nM. |
1683534-96-4 |
DC12302 |
CCR2 antagonist 3
Featured
CCR2 antagonist 3 is a chemokine receptor 2 (CCR2) antagonist. |
1380100-86-6 |
DC20876 |
CCT 068127
CCT 068127 (CCT68127) is a novel potent inhibitor of CDK2 and CDK9 with IC50 of 10 and 90 nM for CDK2/E and CDK9/T, respectively. |
660822-23-1 |
DC20875 |
CCT 365623 hydrochloride
CCT 365623 (CCT365623) hydrochloride is a potent, orally active small molecule inhibitor of lysyl oxidase (LOX) with IC50 of 0.89 uM. |
2126136-98-7 |
DC20874 |
CCT 365623
CCT 365623(CCT365623, CCT-365623) is a potent, orally active small molecule inhibitor of lysyl oxidase (LOX) with IC50 of 0.89 uM. |
2126134-01-6 |
DC7803 |
CCT007093
Featured
CCT007093 is a potent PPM1D (WIP1) inhibitor with IC50 of 8.4 μM. |
176957-55-4 |
DC22464 |
CCT-018159
CCT-01815 is a novel potent inhibitor of Hsp90 ATPase activity with IC50 of 7.1 uM. |
171009-07-7 |
DC20872 |
CCT-031374
CCT-031374 is a selective β-catenin signaling inhibitor with IC50 of 6.1 uM. |
442535-46-8 |
DC23168 |
CCT128930
CCT128930 is a potent, selective, ATP-competitive AKT inhibitor with IC50 of 6 nM (AKT2), 28-fold selectivity over the closely related PKA. |
885499-61-6 |
DC23163 |
CCT129202
CCT129202 is a potent, selective, ATP-competitive pan-Aurora kinase inhibitor with IC50 of 42, 198 and 227 nM for Aurora A, Aurora B and Aurora C, respectively. |
942947-93-5 |
DC23828 |
CCT241161
CCT241161 is a potent pan-RAF inhibitor with IC50 of 30, 15 and 6 nM for BRAF, V600E-BRAF and C-RAF, also potently inhibits SRC and LCK (IC50=10 and 3 nM, respectively).. |
1163719-91-2 |
DC10911 |
CCT241736
Featured
CCT241736 is a novel, orally bioavailable Dual FLT3-Aurora Kinase Inhibitor. |
1402709-93-6 |
DC12549 |
CCX-354
CCX-354 (GSK-2941266, CCX354-C, CCX354) is a potent, selective, orally-available CCR1 antagonist for the treatment of inflammatory diseases such as rheumatoid arthritis (RA).. |
1010073-75-2 |
DC20332 |
CD38 inhibitor 78c
Featured
CD38 inhibitor 78c is a potent, specific, reversible CD38 inhibitor with Ki of 14.5 nM for recombinant human CD38. |
1700637-55-3 |
DC20877 |
S8
Cdc25 inhibitor S8 is an anti-fungal small molecule that inhibits cdc25 phosphatase with Ki of 140 uM. |
1227475-09-3 |
DC21877 |
Cdc7 inhibitor
Cdc7 inhibitor is a potent inhibitor of Cdc7 kinase with pIC50 of 10.01 against CDC7/DBF4 in TR-FRET assays.. |
2206698-92-0 |